Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go:
Extended
investment:
Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
The Stem is an online garden centre aiming to become a leading digital brand in the £7.5 billion per annum UK garden retail market. It is on a mission to make plants and gardening more accessible than ever and in the most sustainable way possible. The company has made over 7,880 deliveries to 6,800 customers across London since launching its new website in March 2020. The Stem has a 97% Net Promoter Score (NPS) and 4.97/5* customer rating. The company will use the investment to expand its product categories and catchment area, build its team and brand, develop its content platform and supply chain.
days to go:
Expired
investment:
£550,008
The Cheeky Panda (TCP) is a B Corp that offers a range of sustainable bamboo tissue and hygiene products available across Europe, the USA, China, and the Middle East. It asserts that its products are on the shelves of some of the World's top retailers including, Waitrose, Boots, MonoPrix and Carrefour. The company has sold over 12 million products across 25 countries and aims to become a contender in the overall hygiene market that is valued at over $200 billion a year. TCP featured in Sunday Times 'Fast Track – 'Ones to Watch' list, won Ocados rising stars best plant-based product in 2021, and launched with Waitrose in over 200 stores. TCP will use the investment to strengthen its management team in the run-up to IPO, focus on marketing and brand awareness to grow D2C sales, and oversee product launches with major retailers.
days to go:
Expired
investment:
£2,400,550
Taska is a fishing tackle brand that has been producing its own products since 2011. In 2017, it was acquired by LetsGetFishing LTD. Taska develops and designs its own products, and currently, it has over 400 products available. It aims to expand and launch its products into European markets by engaging with retailers/wholesalers via trade shows. It has built over 141,000 Facebook followers in the UK. Taska believes that it can replicate its social media success in the European market and organically grow sales through product savvy anglers. In the last 12 months, Taska had £1,000,000+ sales with a Net Profit of £9400.
days to go:
Expired
investment:
£69,560
Please watch the video for more information
days to go:
Expired
investment:
£964,550
Forth allows users to track their wellbeing to see what impact their lifestyle is having on their health. It allows users to maximise their performance during athletics, keep track of their inner health and focus on things they may need to work on for greater overall wellbeing.
days to go:
Expired
investment:
£165,760
GP Nutrition is a nutrition company that creates products meant to deliver sustainable weight loss. This award-winning company was created by Gabriela Peacock, a celebrity nutritionist. It has 13,000 global customers who have bought more than 30,000 packs. In June'19, the company reached trading of £50k per month. It has produced 22 products that are now sold in 30 countries. GP Nutrition has delivered revenue of £377k and an EBITDA of £813,389. Nutrition's vision is to solve the 95% failure rate of diets in the USA and the UK.
days to go:
Expired
investment:
£309,890
